ArticleJournal of biological engineering2026
A strategy of 3D-printed Ta4C3 MXenes nanohydroxyapatite/methacryloylated silk fibroin scaffolds for postsurgical management of osteosarcoma.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The postoperative repair of bone tumors remains a significant clinical challenge requiring urgent solutions, and this holds particularly true for regenerating large bone defects, completely removing residual tumor cells, and effectively preventing and controlling postoperative infections. The efficacy of traditional single treatments is limited, as they generally target only one of these challenges. To overcome this dilemma, this study designed a multifunctional composite nanoscaffold by applying Ta4C3 MXenes nanosheets to the surface of a 3D printed nano-hydroxyapatite (nHA)/methacrylated silk fibroin (MASF) composite scaffold through in situ anchoring. 3D printing technology fabricated a porous hierarchical architecture matching the target bone defect, which provides a suitable three-dimensional microenvironment for bone cell adhesion, proliferation, and differentiation. The main inorganic component of natural bone, nHA, was included to promote bone tissue mineralization. Additionally, with good biocompatibility and degradability, MASF acts as the organic matrix and facilitates the stable loading of the Ta4C3 MXenes nanosheets. To be more specific, the introduction of Ta4C3 MXenes nanosheets endows the scaffold with excellent photothermal conversion capabilities, enabling the generation of precise and controllable local high temperatures upon near-infrared light irradiation. This property allows it to efficiently kill residual tumor cells through thermal ablation while also exhibiting excellent broad-spectrum antibacterial activity through its thermal effects. This implantable material integrates bone defect repair, tumor clearance, and anti-infection functions, thereby effectively solving the limitations of traditional single therapies. It also provides new ideas for the clinical treatment of tumor-related bone defects and exhibits great application prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.